NCT07227597
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07227597
Title A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries ISR

Facility Status City State Zip Country Details
Rambam Health Care Campus ( Site 0602) RECRUITING Haifa 3109601 Israel Details
Sheba Medical Center ( Site 0601) RECRUITING Ramat Gan 5265601 Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field